Mobile

A randomized, double-blind, placebo-controlled two-year trial to examine the changes in Exercise Endurance and COPD Patients Treated with Tiotropium (Spiriva (R) HandiHaler (R)) 18 µg once daily (EXAC...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004610-41

A randomized, double-blind, placebo-controlled two-year trial to examine the changes in Exercise Endurance and COPD Patients Treated with Tiotropium (Spiriva (R) HandiHaler (R)) 18 µg once daily (EXACTT trial)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily, in patients with COPD compared to placebo.

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease (COPD)

Liens